Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar 8:11:17.
doi: 10.1186/1471-230X-11-17.

Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study

Affiliations

Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study

Marc De Hert et al. BMC Gastroenterol. .

Abstract

Background: Antipsychotic are the cornerstone in the treatment of schizophrenia. They also have a number of side-effects. Constipation is thought to be common, and a potential serious side-effect, which has received little attention in recent literature.

Method: We performed a retrospective study in consecutively admitted patients, between 2007 and 2009 and treated with antipsychotic medication, linking different electronic patient data to evaluate the prevalence and severity of constipation in patients with schizophrenia under routine treatment conditions.

Results: Over a period of 22 months 36.3% of patients (99) received at least once a pharmacological treatment for constipation. On average medication for constipation was prescribed for 273 days. Severe cases (N = 50), non-responsive to initial treatment, got a plain x-ray of the abdomen. In 68.4% fecal impaction was found.

Conclusion: A high prevalence of constipation, often severe and needing medical interventions, was confirmed during the study period. Early detection, monitoring over treatment and early intervention of constipation could prevent serious consequences such as ileus.

PubMed Disclaimer

References

    1. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RIG, Möller HJ. Cardiovascular Disease and Diabetes in People with Severe Mental Illness. Position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) Eur Psychiatry. 2009;24:412–424. doi: 10.1016/j.eurpsy.2009.01.005. - DOI - PubMed
    1. De Hert M, van Winkel R, Silic A, Van Eyck D, Peuskens J. Physical health management in psychiatric settings. Eur Psychiatry. 2010;25(Suppl 2):S22–28. doi: 10.1016/S0924-9338(10)71702-8. - DOI - PubMed
    1. Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, Hennekens C, Lambert M, Leucht S, Maj M, McIntyre RS, Naber D, Newcomer JW, Olfson M, Osby U, Sartorius N, Lieberman JA. Cormorbid somatic illnesses in patients with severe mental disorders: clinical, policy and research challenges. J Clin Psychiatry. 2008;69:514–159. doi: 10.4088/JCP.v69n0401. - DOI - PubMed
    1. Leucht S, Burkard T, Henderson J, Maj M, Sartorius N. Physical illness and schizophrenia. Acta Psychiatr Scand. 2007;116(5):317–333. doi: 10.1111/j.1600-0447.2007.01095.x. - DOI - PubMed
    1. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT Jr, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004;161:1334–1349. doi: 10.1176/appi.ajp.161.8.1334. - DOI - PubMed

Publication types

MeSH terms